Related Experiment Video
Updated: Feb 6, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Pharmacokinetic Properties of the Nephrotoxin Orellanine in Rats
Deman Najar1, Börje Haraldsson2, Annika Thorsell3
1Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden. deman.najar@neuro.gu.se.
Abstract:
Orellanine is a nephrotoxin found in mushrooms of the Cortinarius family. Accidental intake of this substance may cause renal failure. Orellanine is specific for proximal tubular cells and could, therefore, potentially be used as treatment for metastatic renal cancer, which originates from these cells. However, more information is needed about the distribution and elimination of orellanine from the body to understand its potential use for therapy. In this study, 5 mg/kg orellanine (unlabeled and ³H-labeled) was injected intravenously in rats (Wistar and Sprague Dawley). Distribution was measured (Wistar rats, n = 10, n = 12) using radioluminography and the highest amount of orellanine was found in the kidney cortex and bladder at all time-points investigated. The pharmacokinetic properties of orellanine was investigated using LC-MS/MS and β-scintillation to measure the amount of orellanine in plasma. Three groups of rats were investigated: control rats with intact kidneys (n = 10) and two groups with bilateral renal artery ligation (n = 7) where animals in one of these groups were treated with peritoneal dialysis (n = 8). Using LC-MS/MS, the half-life of orellanine was found to be 109 ± 6 min in the controls. In the groups with ligated renal arteries, orellanine had a half-life of 756 ± 98 min without and 238 ± 28 min with dialysis. Thus, orellanine was almost exclusively eliminated by glomerular filtration as well as by peritoneal dialysis.
Insights
Orellanine, a mushroom toxin, concentrates in kidneys. Its elimination primarily occurs through glomerular filtration and peritoneal dialysis, suggesting potential therapeutic applications.
Area of Science:
- Toxicology
- Pharmacokinetics
- Nephrology
Background:
- Orellanine, a nephrotoxin from Cortinarius mushrooms, targets proximal tubular cells.
- Potential therapeutic use in metastatic renal cancer due to cell specificity.
- Limited understanding of orellanine's distribution and elimination hinders therapeutic development.
Purpose of the Study:
- To investigate the distribution and pharmacokinetic properties of orellanine in rats.
- To determine orellanine elimination pathways, including glomerular filtration and peritoneal dialysis.
Main Methods:
- Intravenous injection of unlabeled and ³H-labeled orellanine (5 mg/kg) in Wistar and Sprague Dawley rats.
- Distribution analysis using radioluminography.
- Pharmacokinetic analysis via LC-MS/MS and β-scintillation in control and renal artery-ligated rats, with and without peritoneal dialysis.
Main Results:
- Highest orellanine concentrations detected in kidney cortex and bladder.
- Orellanine half-life: 109 ± 6 min in controls.
- Half-life significantly increased in renal artery-ligated rats (756 ± 98 min without dialysis, 238 ± 28 min with dialysis).
Conclusions:
- Orellanine is primarily eliminated via glomerular filtration.
- Peritoneal dialysis effectively enhances orellanine elimination.
- Findings support further research into orellanine's therapeutic potential for renal cell carcinoma.
Related Concept Videos
Pharmacokinetics: Overview
Physical and Chemical Properties of Matter
Properties of Transition Metals
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...

